28 September 2018 1 Min Read
US stops imports from China's Zhejiang Huahai after heart drug recall
The Chinese maker of valsartan recalled the product from consumers in the US in July because an impurity linked to cancer had been detected
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In